Kyverna Therapeutics KYTX
NASDAQ KYTX
$8.28 -0.07 (-0.84%)
As of: Sep 4, 2026 · 3:55 PM EDT

Kyverna Therapeutics (KYTX) Net Shares Issued and Repurchased (2024 - 2026)

Analysis

Kyverna Therapeutics (KYTX) Net Shares Issued and Repurchased (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued and Repurchased (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Kyverna Therapeutics 505.44 Mn 505.44 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 1.85 Mn
Dec 31, 2025 4.08 Mn
Mar 31, 2025 687,679.00
Dec 31, 2024 4.42 Mn
Mar 31, 2024 286,868.00